Article
Newly Diagnosed Patients With PAH Benefit From Earlier Initiation of Therapy
Rating:
0.0
Views:
74
Likes:
1
Library:
1
Patients with pulmonary arterial hypertension (PAH) who are treated with selexipag within 6 months of their diagnosis had a reduced risk of morbidity/mortality compared with patients who were treated longer than 6 months after diagnosis.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value